kanamycin a has been researched along with 3'-hydroxy-5'-(4-isobutylpiperazinyl)benzoxazinorifamycin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bera, S; Mondal, D | 1 |
| Amitani, R; Kuze, F; Murayama, T; Suzuki, K; Tanaka, E; Yamamoto, T | 1 |
| Grosset, J; Ji, B; Lounis, N; Truffot-Pernot, C | 1 |
1 review(s) available for kanamycin a and 3'-hydroxy-5'-(4-isobutylpiperazinyl)benzoxazinorifamycin
| Article | Year |
|---|---|
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
2 other study(ies) available for kanamycin a and 3'-hydroxy-5'-(4-isobutylpiperazinyl)benzoxazinorifamycin
| Article | Year |
|---|---|
Activity of KRM-1648 alone or in combination with both ethambutol and kanamycin or clarithromycin against Mycobacterium intracellulare infections in beige mice.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Colony Count, Microbial; Drug Combinations; Drug Therapy, Combination; Ethambutol; Female; Kanamycin; Lung; Male; Mice; Mycobacterium avium Complex; Rifampin; Rifamycins; Spleen; Tuberculosis | 1996 |
How effective is KRM-1648 in treatment of disseminated Mycobacterium avium complex infections in beige mice?
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Kanamycin; Lung; Male; Mice; Microbial Sensitivity Tests; Mycobacterium avium Complex; Rifamycins; Spleen; Tuberculosis | 1996 |